- Investing Ideas
- /
- Telecom Healthcare Sector
Telecom Healthcare Sector
Results
2309
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2,309 companies
Medical Facilities
Market Cap: CA$299.2m
Through its subsidiaries, owns and operates specialty surgical hospitals and ambulatory surgery center in the United States.
DR
CA$15.54
7D
2.2%
1Y
30.7%
Canopy Growth
Market Cap: CA$298.9m
Engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally.
WEED
CA$2.29
7D
25.8%
1Y
-84.5%
Monash IVF Group
Market Cap: AU$331.2m
Provides assisted reproductive and specialist women imaging services in Australia and Malaysia.
MVF
AU$0.85
7D
1.8%
1Y
-42.0%
Tevogen Bio Holdings
Market Cap: US$211.5m
A clinical-stage specialty immunotherapy company, develops off-the-shelf precision T cell therapies for the treatment of infectious diseases, cancers, and other disorders.
TVGN
US$1.13
7D
3.7%
1Y
37.8%
Integrated Diagnostics Holdings
Market Cap: US$209.3m
Operates as a consumer healthcare company that provides medical diagnostics services to patients.
IDHC
US$0.36
7D
3.4%
1Y
12.3%
AirSculpt Technologies
Market Cap: US$208.7m
Focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States, Canada, and the United Kingdom.
AIRS
US$3.57
7D
19.4%
1Y
-23.4%
Codexis
Market Cap: US$207.9m
Provides enzymatic solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, and enhance novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China.
CDXS
US$2.47
7D
0.4%
1Y
-31.6%
SOPHiA GENETICS
Market Cap: US$207.8m
Operates as a cloud-native software technology company in the healthcare space.
SOPH
US$2.96
7D
1.1%
1Y
-34.8%
Ocugen
Market Cap: US$207.1m
A biopharmaceutical company, focuses on discovering, developing, and commercializing novel gene and cell therapies, biologic, and vaccines that improve patients’ health.
OCGN
US$0.76
7D
13.2%
1Y
-60.3%
VitaSpring Biomedical
Market Cap: US$207.0m
Focuses on the development of drugs of cell medicine.
VSBC
US$1.00
7D
0%
1Y
n/a
Performant Healthcare
Market Cap: US$204.4m
Provides audit, recovery, and analytics services in the United States.
PHLT
US$2.67
7D
7.2%
1Y
-15.8%
Tenax Therapeutics
Market Cap: US$204.4m
A clinical-stage pharmaceutical company, develops novel cardiopulmonary therapies in the United States.
TENX
US$5.89
7D
5.7%
1Y
66.0%
Prime Medicine
Market Cap: US$203.2m
A biotechnology company, engages in delivering genetic therapies to address the spectrum of diseases by deploying gene editing technology in the United States.
PRME
US$1.59
7D
22.3%
1Y
-77.5%
NervGen Pharma
Market Cap: CA$284.0m
A clinical-stage biotech company together with its subsidiaries, engages in the discovery, development, and commercialization of pharmaceutical treatments for medical conditions related to nervous system damage.
NGEN
CA$4.68
7D
32.2%
1Y
112.7%
Solid Biosciences
Market Cap: US$200.8m
Develops therapies for neuromuscular and cardiac diseases in the United States.
SLDB
US$2.77
7D
0.4%
1Y
-69.1%
BioStem Technologies
Market Cap: US$200.4m
A life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services.
BSEM
US$12.39
7D
-18.0%
1Y
52.2%
Annexon
Market Cap: US$198.6m
A clinical-stage biopharmaceutical company, discovers and develops medicines for treating inflammatory-related diseases.
ANNX
US$2.01
7D
25.6%
1Y
-53.6%
Orthocell
Market Cap: AU$308.5m
A regenerative medicine company, develops and commercializes cell therapies and biological medical devices for the repair of various bone and soft tissue injuries in Australia, the United States, the United Kingdom, and the European Union.
OCC
AU$1.28
7D
-7.6%
1Y
226.9%
Aardvark Therapeutics
Market Cap: US$197.2m
A clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases.
AARD
US$9.89
7D
-5.1%
1Y
n/a
biote
Market Cap: US$197.1m
Operates in practice-building business within the hormone optimization space.
BTMD
US$4.10
7D
2.5%
1Y
-28.7%
OptimizeRx
Market Cap: US$197.0m
A digital health technology company, engages in the provision of tech-enabled marketing solutions for life sciences organizations, healthcare providers, and patients.
OPRX
US$11.43
7D
14.4%
1Y
-9.9%
Lexicon Pharmaceuticals
Market Cap: US$194.4m
A biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease.
LXRX
US$0.54
7D
-23.7%
1Y
-69.8%
ME Therapeutics Holdings
Market Cap: CA$269.8m
A preclinical stage biotechnology company, engages in the development of cancer fighting drugs in the field of immuno-oncology.
METX
CA$10.30
7D
4.4%
1Y
150.6%
4basebio
Market Cap: UK£144.1m
Engages in the research, development, manufacturing, and commercialization of synthetic DNA and RNA products, and targeted non-viral vector solutions in the United States, Europe, and internationally.
4BB
UK£11.25
7D
0%
1Y
-20.2%
Bioventix
Market Cap: UK£143.7m
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide.
BVXP
UK£27.50
7D
-3.5%
1Y
-37.1%
Design Therapeutics
Market Cap: US$190.7m
A clinical-stage biopharmaceutical company, research, designs, develops, and commercializes small molecule therapeutic drugs for the treatment of genetic diseases in the United States.
DSGN
US$3.51
7D
0.3%
1Y
-20.4%
Actuate Therapeutics
Market Cap: US$190.6m
A clinical-stage biopharmaceutical company, develops therapies for the treatment of cancers in the United States.
ACTU
US$10.55
7D
1.9%
1Y
n/a
OmniAb
Market Cap: US$189.6m
A biotechnology company, licenses discovery research technology to pharmaceutical and biotech companies, and academic institutions to enable the discovery of therapeutics in the United States, Europe, Japan, China, and Canada.
OABI
US$1.58
7D
9.7%
1Y
-64.5%
Silence Therapeutics
Market Cap: US$189.4m
A biotechnology company, engages in the discovery and development of novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of specific target genes in hematology, cardiovascular, and rare diseases.
SLN
US$4.37
7D
18.1%
1Y
-81.0%
Fennec Pharmaceuticals
Market Cap: US$188.9m
Operates as a commercial stage biopharmaceutical company in the United States.
FENC
US$6.84
7D
15.0%
1Y
-2.8%
High Tide
Market Cap: CA$262.2m
Engages in the cannabis retail business in Canada, the United States, and internationally.
HITI
CA$3.33
7D
-0.6%
1Y
11.4%
Baird Medical Investment Holdings
Market Cap: US$185.0m
Together with its subsidiaries develops and sells microwave ablation medical devices for minimally invasive tumor treatment in China, Egypt, Indonesia, and the United States.
BDMD
US$5.09
7D
-1.7%
1Y
-54.1%
Pacific Smiles Group
Market Cap: AU$287.7m
Owns and operates dental centers under the Pacific Smiles Dental Centres and Nib Dental Care Centres names in Australia.
PSQ
AU$1.78
7D
1.1%
1Y
-6.3%
OraSure Technologies
Market Cap: US$184.0m
Develops, manufactures, markets, sells, and distributes diagnostic products, specimen collection devices, and other diagnostic products in the United States, Europe, Africa, and internationally.
OSUR
US$2.43
7D
-3.2%
1Y
-50.6%
CARGO Therapeutics
Market Cap: US$184.0m
A clinical-stage biotechnology company, develops chimeric antigen receptor (CAR) T-cell therapies for cancer patients.
CRGX
US$4.12
7D
2.5%
1Y
-79.8%
Cardiff Oncology
Market Cap: US$182.9m
A clinical-stage biotechnology company, develops novel therapies for the treatment of various cancers.
CRDF
US$2.81
7D
5.6%
1Y
-22.6%